AVA
Atlas Venture Advisors Portfolio holdings
AUM
$424M
This Quarter Return
+18.21%
1 Year Return
+0.16%
3 Year Return
+108.89%
5 Year Return
+64.67%
10 Year Return
–
AUM
$73.9M
AUM Growth
+$73.9M
(+12%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 83.7% |
| 2 | Communication Services | 10.79% |
| 3 | Technology | 5.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TBIO
1
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $39.1M | 52.94% | 3,922,008 | – | – |
|
|
BCYC
2
Bicycle Therapeutics
BCYC
$511M
| $18.6M | 25.18% | 1,362,696 | – | – |
|
3
Roku
ROKU
$14.2B
| $5.05M | 6.83% | 57,707 | – | – |
|
4
Datadog
DDOG
$47.7B
| $4.07M | 5.52% | 113,232 | – | – |
|
5
Snap
SNAP
$12.1B
| $2.92M | 3.95% | 245,559 | – | – |
|
6
Larimar Therapeutics
LRMR
$310M
| $2.7M | 3.66% | 3,506,207 | – | – |
|
7
Viridian Therapeutics
VRDN
$1.5B
| $1.41M | 1.91% | 3,142,580 | – | – |
|